Retraction
Accepted on 12 Feb 2026
Retraction: Fexuprazan safeguards the esophagus from hydrochloric acid-induced damage by suppressing the NLRP1/Caspase-1/GSDMD pyroptotic pathway
in Inflammation
Retraction
Accepted on 12 Feb 2026
in Inflammation
Original Research
Accepted on 12 Feb 2026
in Quantitative Psychology and Measurement
Correction
Accepted on 12 Feb 2026
in Surgical Oncology
Original Research
Accepted on 12 Feb 2026
in Clinical Diabetes
Editorial
Accepted on 12 Feb 2026
in Clinical Diabetes
Original Research
Accepted on 12 Feb 2026
in Nuclear Energy
Original Research
Accepted on 12 Feb 2026
in Clinical Diabetes
Original Research
Accepted on 12 Feb 2026
in Quantitative Psychology and Measurement
Original Research
Accepted on 12 Feb 2026
in Microorganisms in Vertebrate Digestive Systems
Original Research
Accepted on 12 Feb 2026
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 12 Feb 2026
in Plant Abiotic Stress
Original Research
Accepted on 12 Feb 2026
in Organizational Psychology
Original Research
Accepted on 12 Feb 2026
in Health Economics
Original Research
Accepted on 12 Feb 2026
in Health Economics
Editorial
Accepted on 12 Feb 2026
in Urban Science
Original Research
Accepted on 12 Feb 2026
in Health Economics